4D MOLECULAR THERAPEUTICS IN's ticker is FDMT and the CUSIP is 35104E100. A total of 99 filers reported holding 4D MOLECULAR THERAPEUTICS IN in Q4 2022. The put-call ratio across all filers is 0.37 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,575,312 | -60.2% | 123,748 | -43.5% | 0.14% | -67.0% |
Q2 2023 | $3,960,004 | -50.9% | 219,148 | -53.3% | 0.44% | -47.4% |
Q1 2023 | $8,068,986 | +42.6% | 469,400 | +84.3% | 0.84% | +3.0% |
Q4 2022 | $5,656,887 | +73.5% | 254,700 | +110.7% | 0.81% | +59.8% |
Q3 2021 | $3,261,000 | +34.4% | 120,900 | +19.9% | 0.51% | +36.2% |
Q2 2021 | $2,427,000 | -35.0% | 100,800 | +17.1% | 0.37% | -44.6% |
Q1 2021 | $3,735,000 | – | 86,100 | – | 0.67% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Octagon Capital Advisors LP | 377,777 | $15,659,000 | 5.43% |
BVF INC/IL | 1,106,070 | $45,847,000 | 1.80% |
Eagle Health Investments LP | 50,000 | $2,073,000 | 1.33% |
Ally Bridge Group (NY) LLC | 150,000 | $6,218,000 | 1.07% |
Casdin Capital, LLC | 780,555 | $32,354,000 | 0.96% |
VIKING GLOBAL INVESTORS LP | 3,937,914 | $163,227,000 | 0.45% |
Pinz Capital Management, LP | 19,900 | $825,000 | 0.38% |
ArrowMark Colorado Holdings LLC | 1,063,744 | $44,092,000 | 0.34% |
Perceptive Advisors | 600,256 | $24,881,000 | 0.27% |
ACUTA CAPITAL PARTNERS, LLC | 20,000 | $829,000 | 0.23% |